Please note: You will need to register with Medscape or log in to view this article.
Basecamp for Ketone Monitoring, Part 3: Top 5 Takeaways for Your People With Diabetes
Recent Posts
- Clinical outcomes following supply-driven transition from intranasal to oral desmopressin in AVP-Deficiency- A single centre experience including The Pituitary Foundation Desmopressin Shortage Impact Report.
- Real-world outcomes of cabergoline treatment in non-functioning pituitary adenomas.
- The combined effect of renin angiotensin system blockade and metformin on abdominal aortic aneurysm growth rate in people with diabetes mellitus – A propensity matched retrospective cohort study.
- Diabetes management in people undergoing metabolic-bariatric surgery: A guideline from the Joint British Diabetes Societies for Inpatient Care (JBDS-IP) group.
- Incidental pituitary FDG Uptake on PET-CT: A retrospective review of current practice and outcomes at a UK tertiary centre.